Morgan Stanley

Morgan Stanley’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Morgan Stanley’s Portfolio CDAK Stock Details CDAK Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell
2023 Q1	$2.67K	Sell
2022 Q4	$6.78K	Sell
2022 Q3	$26K	Buy
2022 Q2	$90K	Buy
2022 Q1	$153K	Buy
2021 Q4	$251K	Sell
2021 Q3	$529K	Buy
2021 Q2	$523K	Sell
2021 Q1	$437K	Sell
2020 Q4	$986K	Buy